Article Information
Published By
Online ISSN
History
- Received April 21, 2022
- Accepted August 15, 2022
- Published online October 6, 2022.
Article Versions
- You are currently viewing a previous version of this article (October 6, 2022 - 07:03).
- View the most recent version of this article
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Fiona Cunningham1,5,
- Ellen Caldwell2,
- Nicole Mayer-Hamblett2,3,
- Christopher H. Goss2,3 and
- Marianne S. Muhlebach1,4⇑
- 1Division of Pediatric Pulmonary Medicine, Department of Pediatrics, University of North Carolina, Chapel Hill, , USA
- 2Division of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA , USA
- 3Seattle Children's Research Institute, Seattle, WA, USA
- 4Marsico Lung Institute, University of North Caroline at Chapel Hill, NC USA
- 5at time of manuscript writing
- Corresponding author: Marianne Muhlebach (Marianne_Muhlebach{at}med.unc.edu)
Funding
National Institutes of Health
P30 DK089507; U01 HL114589; UL1 TR00042; UL1 TR002319; UL1TR002489; UM1 HL119073Cystic Fibrosis Foundation
MUHLEB17A0
Article usage
Altmetrics
Vol 9 Issue 1
Table of Contents
Eradication of early MRSA infection in cystic fibrosis – a novel study design for “STAR-ter” trial
